BN Business News
Add your company to Business Communicator →

Innovation & intellectual property · 04/04/2006Updated: 10/17/2026 · 1 min read

U.S. Patent Office Grants Interim Extension to ANTHéLIOS ® SP Topical Cream Patent

Summary

The U.S. Patent and Trademark Office has granted a third one-year extension to the term of U.S. Patent No. 4,585,597, covering the ANTHéLIOS ® SP Topical Cream, which contains the active ingredient Mexoryl ® SX (Ecamsule).

Original source language: Federal Register — Patent and Trademark OfficeOpen original release →

Explore insights

Business insights →